Publications

Doroshow, James H., Sheryl McCoy, John S. Macdonald, Brian F. Issell, Taral Patel, Patrick W. Cobb, Kathleen J. Yost, and James L. Abbruzzese. “Phase II trial of PN401, 5-FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: a Southwest Oncology Group study..” Invest New Drugs 24, no. 6 (November 2006): 537–42. https://doi.org/10.1007/s10637-006-9244-8.

PMID
16832602
Full Text

El-Rayes, Basil F., Shadan Ali, Ifrah F. Ali, Philip A. Philip, James Abbruzzese, and Fazlul H. Sarkar. “Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB..” Cancer Res 66, no. 21 (November 1, 2006): 10553–59. https://doi.org/10.1158/0008-5472.CAN-06-2333.

PMID
17079479
Full Text

Tsuda, Naotake, Satoshi Ishiyama, Yufeng Li, Constantin G. Ioannides, James L. Abbruzzese, and David Z. Chang. “Synthetic microRNA designed to target glioma-associated antigen 1 transcription factor inhibits division and induces late apoptosis in pancreatic tumor cells..” Clin Cancer Res 12, no. 21 (November 1, 2006): 6557–64. https://doi.org/10.1158/1078-0432.CCR-06-0588.

PMID
17085671
Full Text

Fanucchi, Michael P., Frank V. Fossella, Robert Belt, Ronald Natale, Panos Fidias, David P. Carbone, Ramaswamy Govindan, et al. “Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer..” J Clin Oncol 24, no. 31 (November 1, 2006): 5025–33. https://doi.org/10.1200/JCO.2006.06.1853.

PMID
17075122
Full Text

Whitehead, Robert P., Sheryl McCoy, Saul E. Rivkin, Howard M. Gross, Marcel E. Conrad, Gary C. Doolittle, Robert A. Wolff, J Wendall Goodwin, Shaker R. Dakhil, and James L. Abbruzzese. “A Phase II trial of epothilone B analogue BMS-247550 (NSC #710428) ixabepilone, in patients with advanced pancreas cancer: a Southwest Oncology Group study..” Invest New Drugs 24, no. 6 (November 2006): 515–20. https://doi.org/10.1007/s10637-006-8440-x.

PMID
16699973
Full Text

Potti, Anil, Holly K. Dressman, Andrea Bild, Richard F. Riedel, Gina Chan, Robyn Sayer, Janiel Cragun, et al. “Genomic signatures to guide the use of chemotherapeutics..” Nat Med, November 2006. https://doi.org/10.1038/nm1491.

PMID
17057710
Full Text

Morse, M., P. Wu, S. Choi, T. H. Kim, A. S. Brown, M. Losurdo, and G. Bruno. “Structural and optical characterization of GaN heteroepitaxial films on SiC substrates.” Applied Surface Science 253, no. 1 SPEC. ISS. (October 31, 2006): 232–35. https://doi.org/10.1016/j.apsusc.2006.05.097.

Full Text

Gong, Z., J. Yang, M. Yang, F. Wang, Q. Wei, R. M. Tanguay, and T. Wu. “Benzo(a)pyrene inhibits expression of inducible heat shock protein 70 in vascular endothelial cells..” Toxicol Lett 166, no. 3 (October 25, 2006): 229–36. https://doi.org/10.1016/j.toxlet.2006.07.307.

PMID
16962263
Full Text

Das, Prajnan, Robert A. Wolff, James L. Abbruzzese, Gauri R. Varadhachary, Douglas B. Evans, Jean Nicolas Vauthey, Andrew Baschnagel, et al. “Concurrent capecitabine and upper abdominal radiation therapy is well tolerated..” Radiat Oncol 1 (October 24, 2006). https://doi.org/10.1186/1748-717X-1-41.

PMID
17062148
Full Text

Vlahovic, G., Z. N. Rabbani, J. E. Herndon, M. W. Dewhirst, and Z. Vujaskovic. “Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-beta and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation..” Br J Cancer 95, no. 8 (October 23, 2006): 1013–19. https://doi.org/10.1038/sj.bjc.6603366.

PMID
17003785
Full Text

Pages